Trial: 201910170

A Phase 1b, Master Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 in Subjects with Advanced Solid Tumors With KRAS p.G12C Mutation



Principal Investigator

Govindan, Ramaswamy

Disease Site

Breast; Esophagus; Lung; Lung Cancer – Non-small Cell; Melanoma, Skin; Sarcoma; Urinary Bladder

Learn more about this study at: